Sequent Scientific Limited — Board Meeting, 08-08-2025: Outcome of Board Meeting

Sequent Scientific's Board has approved the financial results for the quarter ended June 30, 2025. The company reported consolidated revenue of ₹441.42 Cr, a good jump from previous year. Consolidated profit after tax came in at ₹17.57 Cr, significantly higher than last year. Total comprehensive income saw a massive rebound to ₹49.32 Cr. Key strategic update: The company incurred ₹1.25 Cr in expenses related to its proposed Composite Scheme of Amalgamation, a significant restructuring move pending regulatory approvals. Investors should watch for further updates on this strategic merger.